Amy Liao, PhD
Dr. Amy Liao is the Co-Founder and Chief Executive Officer of Couragene since its inception in 2022.
Prior to starting Couragene, Amy was a co-founder and CEO of GENEWIZ, and then President of Brooks Life Sciences Services after GENEWIZ was acquired by Brooks Automation.
Dr. Liao has had a long and distinguished career in genomics services and sciences, with many academic and business achievements to date. In 2020, in honoring an individual for a lifetime commitment and important contributions to patient healthcare, Dr. Liao received the coveted Biomedical Engineering Society's Wallace A. Coulter award for innovation in healthcare. In 2010, Dr. Liao along with Dr. Steve Sun, co-founder of GENEWIZ, received the Ernst & Young Entrepreneur Of The Year® 2010 Award in the Services category for New Jersey.
Dr. Liao graduated with a bachelor's degree from Nankai University, a master's degree from Tsinghua University, and a PhD in Biochemistry and Cell Biology from SUNY at Stony Brook. Dr. Liao carried out her postdoctoral studies at Columbia University before she co-founded GENEWIZ with her business partner in 1999.